---
status: archived
lifecycle: history
owner: governance-team
last-reviewed: 2026-06-22
archived-since: 2026-06-22
note: "P45 审计: 历史决策/phase closeout, 标记 archived"
---

# Phase 12-14 cross-review

> Date: 2026-06-01
> Status: review complete; design guardrails proposed
> Review target: `../design/phase12-14-architecture-design.md`
> Source refs: `../../plans/archive/phase12-planning-gate.md`, `../../plans/archive/phase12-program-plan.md`, `../../plans/archive/phase13-metacognition-preplanning.md`, `../../plans/archive/phase14-deferred-ecosystem-backlog.md`

---

## 1. Review result

The Phase 12-14 split is directionally correct:

- Phase 12 is the capability ecosystem foundation.
- Phase 13 is supervised metacognition.
- Phase 14 is deferred ecosystem expansion.

The main residual risk is not architecture direction. The risk is mechanism drift: plan text may still be interpreted as execution, deferred scope may sneak back into Phase 12, or Phase 13's self-healing language may be treated as permission for live mutation.

---

## 2. Required governance guardrails

| Guardrail | Severity | Required support |
|-----------|----------|------------------|
| Promotion envelope | P0 | Live SSOT changes require a human-approved task with evidence, rollback, and verification |
| Deferred scope ledger | P1 | Phase 14 backlog must remain visible and reviewable |
| Capability registry schema | P1 | Phase 12 W1 must define schema before registry records become authoritative |
| Scenario trace evidence | P1 | Phase 12 W2/W3 must produce reproducible traces |
| Mutation proposal envelope | P0 | Phase 13 W4 cannot mutate live state without approval and rollback evidence |

---

## 3. Technical support assessment

The existing `.omo` mechanism is sufficient for pre-planning and review, but not sufficient for later execution unless Phase 12 W1/W2 add these technical supports:

1. Capability metamodel and registry schema.
2. Scenario trace evidence schema.
3. Promotion envelope for phase/state changes.
4. Mutation proposal envelope for Phase 13.
5. Deferred scope ledger, initially represented by `phase14-deferred-ecosystem-backlog.md`.

These supports should be implemented only after Phase 12 is legitimately promoted from pre-planning.

---

## 4. Open issues to resolve before Phase 12 execution

| Issue | Current concern | Resolution path |
|-------|-----------------|-----------------|
| Health score vs ecosystem maturity | Phase 12 should not appear to regress `health_score` from 97 to 90 | Use `ecosystem_maturity_score` for Phase 12 maturity |
| Package dry-run audit | A dry-run should not require installed dependencies to match declarations | Audit diff explainability, not mutation |
| Phase 14 expedited path | Human reprioritization must not bypass safety | Require risk acceptance + security review + rollback gate |
| Phase 13 self-healing | Self-healing can be misread as live mutation | Add mutation gate and keep auto-apply disabled |

---

## 5. Decision

Proceed with the Phase 12-14 architecture design as a pre-planning design package. Do not create Phase 12, 13, or 14 active tasks from this review. The next valid execution step remains Phase 11 completion and human ratification of Phase 12 entry.
